Literature DB >> 29651499

AKI biomarkers are poor discriminants for subsequent need for renal replacement therapy, but do not disqualify them yet.

Harm-Jan de Grooth1, Jean-Jacques Parienti2,3, Miet Schetz4.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29651499     DOI： 10.1007/s00134-018-5151-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  14 in total

Review 1.  New strategies for clinical trials in patients with sepsis and septic shock.

Authors:  J Cohen; G Guyatt; G R Bernard; T Calandra; D Cook; D Elbourne; J Marshall; A Nunn; S Opal
Journal:  Crit Care Med       Date:  2001-04       Impact factor: 7.598

2.  What price perfection? Calibration and discrimination of clinical prediction models.

Authors:  G A Diamond
Journal:  J Clin Epidemiol       Date:  1992-01       Impact factor: 6.437

Review 3.  A comparison of goodness-of-fit tests for the logistic regression model.

Authors:  D W Hosmer; T Hosmer; S Le Cessie; S Lemeshow
Journal:  Stat Med       Date:  1997-05-15       Impact factor: 2.373

4.  Measurement of AKI biomarkers in the ICU: still striving for appropriate clinical indications.

Authors:  John R Prowle
Journal:  Intensive Care Med       Date:  2015-01-22       Impact factor: 17.440

5.  Validating benefit of biomarker-directed therapy for acute kidney injury: can you have your cake and eat it?

Authors:  J R Prowle; M Schetz
Journal:  Intensive Care Med       Date:  2017-02-16       Impact factor: 17.440

6.  A multibiomarker-based outcome risk stratification model for adult septic shock*.

Authors:  Hector R Wong; Christopher J Lindsell; Ville Pettilä; Nuala J Meyer; Simone A Thair; Sari Karlsson; James A Russell; Christopher D Fjell; John H Boyd; Esko Ruokonen; Michael G S Shashaty; Jason D Christie; Kimberly W Hart; Patrick Lahni; Keith R Walley
Journal:  Crit Care Med       Date:  2014-04       Impact factor: 7.598

7.  Use and misuse of the receiver operating characteristic curve in risk prediction.

Authors:  Nancy R Cook
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

8.  Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial.

Authors:  Alexander Zarbock; John A Kellum; Christoph Schmidt; Hugo Van Aken; Carola Wempe; Hermann Pavenstädt; Andreea Boanta; Joachim Gerß; Melanie Meersch
Journal:  JAMA       Date:  2016 May 24-31       Impact factor: 56.272

Review 9.  Sepsis: rethinking the approach to clinical research.

Authors:  John C Marshall
Journal:  J Leukoc Biol       Date:  2008-01-02       Impact factor: 4.962

Review 10.  Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis.

Authors:  Sebastian J Klein; Anna K Brandtner; Georg F Lehner; Hanno Ulmer; Sean M Bagshaw; Christian J Wiedermann; Michael Joannidis
Journal:  Intensive Care Med       Date:  2018-03-14       Impact factor: 17.440
View more
  4 in total

1.  Focus on critical care nephrology.

Authors:  Michaël Darmon; Michael Joannidis; Miet Schetz
Journal:  Intensive Care Med       Date:  2019-07-11       Impact factor: 17.440

2.  Performance of Doppler-based resistive index and semi-quantitative renal perfusion in predicting persistent AKI: results of a prospective multicenter study.

Authors:  Michael Darmon; Aurelie Bourmaud; Marie Reynaud; Stéphane Rouleau; Ferhat Meziani; Alexandra Boivin; Mourad Benyamina; François Vincent; Alexandre Lautrette; Christophe Leroy; Yves Cohen; Matthieu Legrand; Jérôme Morel; Jeremy Terreaux; David Schnell
Journal:  Intensive Care Med       Date:  2018-10-05       Impact factor: 17.440

Review 3.  Biomarker-Guided Risk Assessment for Acute Kidney Injury: Time for Clinical Implementation?

Authors:  Christian Albert; Michael Haase; Annemarie Albert; Antonia Zapf; Rüdiger Christian Braun-Dullaeus; Anja Haase-Fielitz
Journal:  Ann Lab Med       Date:  2020-08-25       Impact factor: 3.464

Review 4.  Mechanistic Aspects and Therapeutic Potential of Quercetin against COVID-19-Associated Acute Kidney Injury.

Authors:  Lúcio Ricardo Leite Diniz; Marilia Trindade de Santana Souza; Allana Brunna Sucupira Duarte; Damião Pergentino de Sousa
Journal:  Molecules       Date:  2020-12-07       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.